Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)

BACKGROUND: Gynecological cancer is one of the highest risk factors for cancer-associated thrombosis (CAT). Although low-molecular-weight heparin (LMWH) is recommended as an anticoagulant for treating CAT, recent studies have shown that direct oral anticoagulants (DOACs) are an acceptable alternativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Oride, Tadashi, Sawada, Kenjiro, Shimizu, Aasa, Kinose, Yasuto, Takiuchi, Tsuyoshi, Kodama, Michiko, Hashimoto, Kae, Kobayashi, Eiji, Nakatani, Eiji, Kimura, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184411/
https://www.ncbi.nlm.nih.gov/pubmed/37183245
http://dx.doi.org/10.1186/s12959-023-00500-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184411/
https://www.ncbi.nlm.nih.gov/pubmed/37183245
http://dx.doi.org/10.1186/s12959-023-00500-8

Ejemplares similares